Display Settings:

Format
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 5

1.

New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.

Ché C, Yang G, Thiot C, Lacoste MC, Currie JC, Demeule M, Régina A, Béliveau R, Castaigne JP.

J Med Chem. 2010 Apr 8;53(7):2814-24. doi: 10.1021/jm9016637.

PMID:
20210346
[PubMed - indexed for MEDLINE]
2.

Transport characteristics of a novel peptide platform for CNS therapeutics.

Bertrand Y, Currie JC, Demeule M, Régina A, Ché C, Abulrob A, Fatehi D, Sartelet H, Gabathuler R, Castaigne JP, Stanimirovic D, Béliveau R.

J Cell Mol Med. 2010 Dec;14(12):2827-39. doi: 10.1111/j.1582-4934.2009.00930.x.

PMID:
19818094
[PubMed - indexed for MEDLINE]
3.

Approaches to transport therapeutic drugs across the blood-brain barrier to treat brain diseases.

Gabathuler R.

Neurobiol Dis. 2010 Jan;37(1):48-57. doi: 10.1016/j.nbd.2009.07.028. Epub 2009 Aug 5. Review.

PMID:
19664710
[PubMed - indexed for MEDLINE]
4.

Blood-brain barrier transport of drugs for the treatment of brain diseases.

Gabathuler R.

CNS Neurol Disord Drug Targets. 2009 Jun;8(3):195-204. Review.

PMID:
19601817
[PubMed - indexed for MEDLINE]
5.

Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.

Demeule M, Currie JC, Bertrand Y, Ché C, Nguyen T, Régina A, Gabathuler R, Castaigne JP, Béliveau R.

J Neurochem. 2008 Aug;106(4):1534-44. doi: 10.1111/j.1471-4159.2008.05492.x. Epub 2008 May 19.

PMID:
18489712
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk